Ameriprise’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,619
| Closed | -$226K | – | 4006 |
|
|
2023
Q4 | $226K | Buy |
+7,619
| New | +$152K | ﹤0.01% | 3695 |
|
|
2023
Q3 | – | Sell |
-41,815
| Closed | -$789K | – | 3991 |
|
|
2023
Q2 | $789K | Sell |
41,815
-245,052
| -85% | -$2.89M | ﹤0.01% | 3273 |
|
|
2023
Q1 | $1.1M | Sell |
286,867
-882
| -0.3% | -$3.76K | ﹤0.01% | 3102 |
|
|
2022
Q4 | $1.43M | Buy |
287,749
+162,984
| +131% | +$884K | ﹤0.01% | 2959 |
|
|
2022
Q3 | $596K | Sell |
124,765
-1,451
| -1% | -$7.65K | ﹤0.01% | 3319 |
|
|
2022
Q2 | $568K | Buy |
126,216
+676
| +0.5% | +$2.94K | ﹤0.01% | 3353 |
|
|
2022
Q1 | $598K | Buy |
+125,540
| New | +$695K | ﹤0.01% | 3418 |
|
|
2021
Q2 | – | Sell |
-5,595,683
| Closed | -$45.3M | – | 3985 |
|
|
2021
Q1 | $45.3M | Buy |
5,595,683
+3,738,190
| +201% | +$30.5M | 0.02% | 815 |
|
|
2020
Q4 | $12M | Buy |
1,857,493
+439,857
| +31% | +$2.57M | ﹤0.01% | 1603 |
|
|
2020
Q3 | $5.1M | Sell |
1,417,636
-19,513
| -1% | -$78.8K | ﹤0.01% | 2068 |
|
|
2020
Q2 | $6.61M | Buy |
1,437,149
+1,412,568
| +5,747% | +$6.01M | ﹤0.01% | 1860 |
|
|
2020
Q1 | $84K | Buy |
24,581
+1,619
| +7% | +$7.08K | ﹤0.01% | 3548 |
|
|
2019
Q4 | $117K | Buy |
22,962
+2,214
| +11% | +$7.51K | ﹤0.01% | 3633 |
|
|
2019
Q3 | $50K | Buy |
+20,748
| New | +$55.1K | ﹤0.01% | 3667 |
|
|
2018
Q3 | – | Sell |
-127,776
| Closed | -$1.24M | – | 3792 |
|
|
2018
Q2 | $1.24M | Buy |
127,776
+21,872
| +21% | +$231K | ﹤0.01% | 2938 |
|
|
2018
Q1 | $1.11M | Buy |
+105,904
| New | +$1.05M | ﹤0.01% | 2937 |
|
|
2017
Q4 | – | Sell |
-208,574
| Closed | -$1.59M | – | 3750 |
|
|
2017
Q3 | $1.59M | Sell |
208,574
-9,819
| -4% | -$65.2K | ﹤0.01% | 2726 |
|
|
2017
Q2 | $1.55M | Sell |
218,393
-176,377
| -45% | -$807K | ﹤0.01% | 2734 |
|
|
2017
Q1 | $1.53M | Buy |
+394,770
| New | +$1.15M | ﹤0.01% | 2700 |
|
|
2016
Q2 | – | Sell |
-11,988
| Closed | -$102K | – | 3856 |
|
|
2016
Q1 | $102K | Sell |
11,988
-5,150
| -30% | -$43.6K | ﹤0.01% | 3619 |
|
|
2015
Q4 | $233K | Buy |
17,138
+2,233
| +15% | +$27.5K | ﹤0.01% | 3596 |
|
|
2015
Q3 | $143K | Buy |
14,905
+158
| +1% | +$2.31K | ﹤0.01% | 3693 |
|
|
2015
Q2 | $212K | Buy |
14,747
+2,704
| +22% | +$29.7K | ﹤0.01% | 3816 |
|
|
2015
Q1 | $108K | Buy |
+12,043
| New | +$87.2K | ﹤0.01% | 3674 |
|
|
2014
Q4 | – | Sell |
-6,415
| Closed | -$68K | – | 4520 |
|
|
2014
Q3 | $68K | Buy |
6,415
+4,242
| +195% | +$48K | ﹤0.01% | 3857 |
|
|
2014
Q2 | $26K | Buy |
2,173
+1,675
| +336% | +$21K | ﹤0.01% | 4200 |
|
|
2014
Q1 | $8K | Sell |
498
-380
| -43% | -$5.99K | ﹤0.01% | 4638 |
|
|
2013
Q4 | $13K | Sell |
878
-4,894
| -85% | -$75.2K | ﹤0.01% | 4268 |
|
|
2013
Q3 | $99K | Sell |
5,772
-219
| -4% | -$3.85K | ﹤0.01% | 3469 |
|
|
2013
Q2 | $99K | Buy |
+5,991
| New | +$97.1K | ﹤0.01% | 3392 |
|
Other funds holding IMGN
Ameriprise's IMGN Position: Q1 2024 in Review
Ameriprise sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 7,619 shares — an estimated $226K sold.
Ameriprise first reported a position in IMGN in Q2 2013 and held it in 30 quarters. The position peaked at $45.3M in Q1 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Ameriprise reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Ameriprise sold 7,619 Immunogen Inc shares in Q1 2024, an estimated $226K.
- Ameriprise first reported a position in Immunogen Inc in Q2 2013 and held it in 30 quarters.
- Ameriprise's Immunogen Inc position peaked at $45.3M in Q1 2021.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Ameriprise's 13F filing for Q1 2024, filed 15 May 2024.